These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 32961217)
1. Superior short-term memory in APOE ε2 carriers across the age range. Zokaei N; Board AG; Slavkova E; E Mackay C; Nobre AC; Husain M Behav Brain Res; 2021 Jan; 397():112918. PubMed ID: 32961217 [TBL] [Abstract][Full Text] [Related]
2. Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40-APOE variants in men. Kulminski AM; Philipp I; Loika Y; He L; Culminskaya I Alzheimers Dement; 2021 Nov; 17(11):1779-1787. PubMed ID: 34310032 [TBL] [Abstract][Full Text] [Related]
3. Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriers. Alexopoulos P; Richter-Schmidinger T; Horn M; Maus S; Reichel M; Sidiropoulos C; Rhein C; Lewczuk P; Doerfler A; Kornhuber J J Alzheimers Dis; 2011; 26(2):207-10. PubMed ID: 21606569 [TBL] [Abstract][Full Text] [Related]
4. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease. Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235 [TBL] [Abstract][Full Text] [Related]
5. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528 [TBL] [Abstract][Full Text] [Related]
6. White matter alterations in cognitively normal apoE ε2 carriers: insight into Alzheimer resistance? Chiang GC; Zhan W; Schuff N; Weiner MW AJNR Am J Neuroradiol; 2012 Aug; 33(7):1392-7. PubMed ID: 22383234 [TBL] [Abstract][Full Text] [Related]
7. Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment. Liu X; Zeng Q; Luo X; Li K; Xu X; Hong L; Li J; Guan X; Xu X; Huang P; Zhang MM; CNS Neurosci Ther; 2023 Feb; 29(2):597-608. PubMed ID: 36468416 [TBL] [Abstract][Full Text] [Related]
8. Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife. Zokaei N; Giehl K; Sillence A; Neville MJ; Karpe F; Nobre AC; Husain M Cortex; 2017 Mar; 88():98-105. PubMed ID: 28086184 [TBL] [Abstract][Full Text] [Related]
9. APOE2: protective mechanism and therapeutic implications for Alzheimer's disease. Li Z; Shue F; Zhao N; Shinohara M; Bu G Mol Neurodegener; 2020 Nov; 15(1):63. PubMed ID: 33148290 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene in physiological and pathological aging. Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061 [TBL] [Abstract][Full Text] [Related]
11. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Berlau DJ; Corrada MM; Head E; Kawas CH Neurology; 2009 Mar; 72(9):829-34. PubMed ID: 19255410 [TBL] [Abstract][Full Text] [Related]
12. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E ε4 and later-life decline in cognitive function and grip strength. Batterham PJ; Bunce D; Cherbuin N; Christensen H Am J Geriatr Psychiatry; 2013 Oct; 21(10):1010-9. PubMed ID: 23567378 [TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype, atrophy, and small vessel disease in Groot C; Sudre CH; Barkhof F; Teunissen CE; van Berckel BNM; Seo SW; Ourselin S; Scheltens P; Cardoso MJ; van der Flier WM; Ossenkoppele R Neurology; 2018 Nov; 91(20):e1851-e1859. PubMed ID: 30341156 [TBL] [Abstract][Full Text] [Related]
15. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843 [TBL] [Abstract][Full Text] [Related]
16. Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia. Ban C; Zhang Q; Feng J; Li H; Qiu Q; Tian Y; Li X BMC Psychiatry; 2017 Dec; 17(1):399. PubMed ID: 29233125 [TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Van Dyk K; Zhou X; Small BJ; Ahn J; Zhai W; Ahles T; Graham D; Jacobsen PB; Jim H; McDonald BC; Nudelman Holohan K; Patel SK; Rebeck GW; Root JC; Saykin AJ; Cohen HJ; Mandelblatt JS; Carroll JE JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33748669 [TBL] [Abstract][Full Text] [Related]
18. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187 [TBL] [Abstract][Full Text] [Related]
19. Short-term memory advantage for brief durations in human APOE ε4 carriers. Zokaei N; Grogan J; Fallon SJ; Slavkova E; Hadida J; Manohar S; Nobre AC; Husain M Sci Rep; 2020 Jun; 10(1):9503. PubMed ID: 32528115 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal change in working memory as a function of APOE genotype in midlife and old age. Greenwood PM; Espeseth T; Lin MK; Reinvang I; Parasuraman R Scand J Psychol; 2014 Jun; 55(3):268-77. PubMed ID: 24853824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]